32454512 |
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Duan, X,
Chen, Z,
Wang, L,
Gao, GF,
Huang, W,
Song, T,
Yuan, Z,
Song, J,
Bi, X,
Zhang, Y,
Yan, J,
Wu, G,
Shi, R,
Wu, L,
Wang, FS,
Shan, C,
Tong, Z,
Zhang, B,
Liu, P,
Han, C,
Qi, J,
Liu, WJ,
Feng, H,
Gao, G,
Hu, X,
Wang, Q
|
Nature |
2020 |
33125711 |
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations
Page, CP,
Wilkinson, T,
Lima, MA,
Elmore, MJ,
Coombes, N,
Yates, EA,
Buttigieg, KR,
Carroll, MW,
Yang, Z,
Karlsson, R,
Staples, KJ,
Chen, YH,
Mycroft-West, CJ,
Tree, JA,
Hogwood, J,
Spalluto, CM,
Turnbull, JE,
Gray, E,
Skidmore, MA,
Singh, D
|
Br J Pharmacol |
2021 |
33820835 |
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Geisbert, TW,
Westendorf, K,
Berens, SJ,
Tycho, SA,
Hendle, J,
Collins, DW,
Pellacani, D,
Jepson, KR,
Corbett, KS,
Muthuraman, K,
Mulligan, MJ,
Graham, BS,
Heinz, BA,
Balasubramaniam, D,
Samanovic, MI,
Mascola, JR,
Jones, BE,
Hinshaw, SJ,
Johnson, NV,
de Vries, M,
Cross, RW,
Abiona, O,
Dittmann, M,
Brown-Augsburger, PL,
Kraft, L,
Borisevich, V,
Davies, J,
Baric, RS,
Barnhart, BC,
Pustilnik, A,
Yang, ES,
Adams, AC,
McLellan, JS,
Cujec, TP,
Zhang, Y,
Piper, MH,
Mohamed, A,
Wang, L,
Hwang, Y,
Wiethoff, CM,
Martinez, DR,
Hsieh, CL,
Goya, R,
Hansen, CL,
Falconer, E,
Foster, D,
Sobhanifar, S,
Bidshahri, R,
Smith, MA,
Higgs, RE,
Wrapp, D,
Blackbourne, JL,
Triana, FJ,
Goldsmith, JA,
Žentelis, S,
Belli, HM,
Xiang, P
|
Sci Transl Med |
2021 |
32653452 |
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
Linhardt, RJ,
Zhang, F,
Woods, RJ,
Fu, L,
Sood, A,
Kim, SY,
Jin, W,
Montgomery, DW,
Fuster, MM,
Grant, OC,
Dordick, JS
|
Antiviral Res |
2020 |
33475701 |
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Nirula, A,
Chen, P,
Shen, L,
Mocherla, B,
Schade, AE,
Kallewaard, NL,
Cardona, J,
Oakley, G,
Custer, KL,
Morris, J,
Ebert, PJ,
Patel, DR,
Heller, B,
Adams, AC,
Skovronsky, DM,
Boscia, J,
Holzer, TR,
Sabo, J,
Stosor, V,
Kumar, P,
Van Naarden, J,
Higgs, RE,
Shawa, I,
Gottlieb, RL,
Durante, M,
Huhn, G,
Klekotka, P
|
JAMA |
2021 |
34200372 |
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin
Urwin, L,
James, DC,
Partridge, LJ,
Green, LR,
Monk, PN,
Nicklin, MJH
|
Cells |
2021 |
33368089 |
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
Yates, EA,
Guimond, SE,
Vicenzi, E,
Li, Y,
Miller, GJ,
Forsyth, NR,
Rudd, TR,
Clementi, M,
Nader, HB,
Elli, S,
Skidmore, MA,
Nunes, QM,
Pagani, I,
Lima, MA,
Ferro, V,
Guerrini, M,
Su, D,
Meneghetti, MCZ,
Mycroft-West, CJ,
Bisio, A,
Fernig, DG,
Turnbull, JE,
Procter, P,
Gandhi, NS,
Mancini, N
|
Thromb Haemost |
2020 |
33131609 |
Human recombinant soluble ACE2 in severe COVID-19
Wenisch, C,
Haider, D,
Puchhammer-Stoeckl, E,
Pawelka, E,
Grieb, A,
Penninger, JM,
Aberle, JH,
Neuhold, S,
Slutsky, AS,
Montserrat, N,
Poglitsch, M,
Traugott, M,
Bergthaler, A,
Stiasny, K,
Mirazimi, A,
Zhang, H,
Zoufaly, A,
Seitz, T,
Hoepler, W,
Laferl, H
|
Lancet Respir Med |
2020 |
34235261 |
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
Bouwman, KM,
Tompkins, SM,
Boons, GJ,
de Vries, RP,
Liu, L,
Chopra, P,
Wolfert, MA,
Li, X
|
ACS Cent Sci |
2021 |
34929169 |
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms
Wade, RC,
Paiardi, G,
Urbinati, C,
Oreste, P,
Richter, S,
Rusnati, M
|
J Biol Chem |
2022 |
32333836 |
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Monteil, V,
Penninger, JM,
Montserrat, N,
Slutsky, AS,
Kwon, H,
Romero, JP,
Leopoldi, A,
Wimmer, RA,
Stahl, M,
Prado, P,
Conder, R,
Hagelkrüys, A,
Hurtado Del Pozo, C,
Mirazimi, A,
Zhang, H,
Prosper, F,
Wirnsberger, G,
Garreta, E
|
Cell |
2020 |
33144565 |
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19
Stockand, JD,
Abd El-Aziz, TM,
Al-Sabi, A
|
Signal Transduct Target Ther |
2020 |
34004056 |
Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs
Plaper, T,
Jazbec, V,
Pichlmair, A,
Govednik, T,
Lainšček, D,
Jerala, R,
Hafner-Bratkovič, I,
Bencina, M,
Orehek, S,
Grass, V,
Bergant, V,
Manček-Keber, M
|
FASEB J |
2021 |
32907861 |
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Carter, L,
Veesler, D,
Chen, RE,
Strauch, EM,
Baker, D,
Kozodoy, L,
Diamond, MS,
Stewart, L,
Coventry, B,
Walls, AC,
Park, YJ,
Miller, L,
Goreshnik, I,
Case, JB,
Cao, L
|
Science |
2020 |